bioAffinity Technologies Inc. (BIAF) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    bioAffinity Technologies ...

    NASDAQ: BIAF · Real-Time Price · USD
    0.29
    0.01 (2.04%)
    At close: Jun 09, 2025, 3:59 PM

    bioAffinity Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -9.04M -7.94M -8.15M -6.33M
    Depreciation & Amortization
    		 605.64K 249.59K 10.18K 4.82K
    Stock-Based Compensation
    		 989.68K 748.82K 248.59K 43.01K
    Other Working Capital
    		 133.85K 603.92K 14.07K 593.8K
    Other Non-Cash Items
    		 989.68K -109.77K 3.71M -244.35K
    Deferred Income Tax
    		 n/a n/a n/a 3.84M
    Change in Working Capital
    		 179.72K 900.79K 114.2K 632.82K
    Operating Cash Flow
    		 -7.26M -6.04M -4.07M -2.05M
    Capital Expenditures
    		 -79.08K -22.9K -219.99K n/a
    Cash Acquisitions
    		 n/a -2.19M n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a n/a
    Investing Cash Flow
    		 -79.08K -2.21M -219.99K n/a
    Debt Repayment
    		 -169.33K -344.98K 584.16K 212.26K
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 1.45M n/a 13.76M 3.11M
    Financial Cash Flow
    		 5.63M -344.98K 14.34M 3.33M
    Net Cash Flow
    		 -1.72M -8.59M 10.05M 1.28M
    Free Cash Flow
    		 -7.34M -6.06M -4.29M -2.05M

    Add to Watchlist